The Asia-Pacific electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems.
The growth of the Asia- Pacific Electrophysiology market is driven by several factors, the most important of which is the technological innovations. Technological innovations and advancements have led to the introduction of new products . The other factors promoting the growth of the market are increasing incidences of chronic diseases, , ease of use and interpretation of medical devices. Factors constraining the growth of the market include reimbursement issues, high cost of the medical devices .Emerging economies, Public awareness for cardiac disease are the major opportunities in the market.
The report segments the market by types( Electrophysiology monitoring devices, Treatment devices) and based on geography(India, China, Japan)Asia-Pacific shows very potential market due to increasing technological innovations, and increasing per capita income and growing economy.
Major companies discussed in this report with their profile and relevant information from market perspective are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic Inc., Microport
What makes our report unique??
1) An extensive research study on the Electrophysiology market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the wearable electronics.
2) We provide the longest segmentation of the market based on products, technology, components, form factor, products application, industry verticals, and geography.
3) This report gives a birds eye-view of the market competitive landscape which includes mergers & acquisitions, collaborations., new product launches and key players in the market.
1.1 Report description
1.2 Research methodology
2. Executive summary
3. MARKET OVERVIEW
3.2 MARKET SIZE AND FORECASTS
3.3 MARKET DYNAMICS
3.3.1 MARKET DRIVERS
126.96.36.199 RAPIDLY INCREASING AGED POPULTAION
188.8.131.52 INCREASING CASES OF CARDIAC DISEASES
184.108.40.206 TECHNOLOGICAL ADVANCEMENTS
3.3.2 MARKET RESTRAINTS
220.127.116.11 HIGH COST OF TREATMENT
18.104.22.168 REGULATORY ISSUES
22.214.171.124 PATIENT PROTECTION AND AFFORDABLE CARE ACT
126.96.36.199 INCREASING HEALTHCARE EXPENDITURE
188.8.131.52 RISING ADOPTION OF ABLATION TECHNIQUES
184.108.40.206 EMERGING ECONOMIES
220.127.116.11 PUBLIC AWARENESS FOR CARDIAC DISEASES
18.104.22.168 HUGE SCOPE FOR CONSOLIDATION
3.3.4 PORTER'S FIVE FORCE ANALYSIS
22.214.171.124 BARGAINING POWER OF SUPPLIERS
126.96.36.199 BARGAINING POWER OF BUYERS
188.8.131.52 THREAT OF SUBSTITUTES
184.108.40.206 THREAT FROM NEW ENTRANT
220.127.116.11 COMPETITIVE RIVALRY
4. Market segmentation
4.1 Market segmentation,by type of products
4.1.1 Electrophysiology monitoring devices
18.104.22.168 Electrocardiograph (ECG)
22.214.171.124 Electroencephalograph (EEG)
126.96.36.199 Electrocorticograph (ECOG)
188.8.131.52 Electromyograph (EMG)
184.108.40.206 Electroretinograph (ERG)
220.127.116.11 Electrooculograph (EOG)
18.104.22.168 Holter monitoring devices
22.214.171.124 X-ray systems
126.96.36.199 Imaging and 3d mapping systems
188.8.131.52 Diagnostic electrophysiology catheters
4.1.2 Electrophysiology treatment devices
184.108.40.206 Implantable cardioverter defibrillators (ICDS)
220.127.116.11 Cardiac resynchronization therapy devices (CRTS)
18.104.22.168.1 Radiofrequency electrophysiology ablation catheters
22.214.171.124.2 Cryoablation electrophysiology catheters
126.96.36.199.3 Laser ablation catheters
188.8.131.52.4 Microwave ablation catheters
4.2 Electrophysiology treatment devices, by geography
5. Competitive Landscape
5.3 Product launches/developments
6. COMPANY PROFILES
6.1 Biosense webster, inc.
6.2 St. Jude medical, inc.
6.3 Japan lifeline co., ltd.
6.4 Biotronik se & co. Kg
6.5 Boston scientific corporation
6.6 Medtronic, inc.
6.7 C. R. Bard, inc.